Keurig Dr Pepper (NASDAQ:KDP – Free Report) had its price objective trimmed by Barclays from $39.00 to $36.00 in a research note issued to investors on Friday morning,Benzinga reports.
Barclays lowered the firm’s price target on Keurig Dr Pepper (KDP) to $36 from $39 and keeps an Overweight rating on the shares as part of a consumer staples Q4 earnings preview. Put simply ...
In a report released today, Lauren Lieberman from Barclays maintained a Buy rating on Keurig Dr Pepper (KDP – Research Report), with a price target of $36.00. The company’s shares closed ...
Keurig Dr Pepper Inc. (NASDAQ:KDP) is a leading non-alcoholic beverage ... On January 17, Lauren Lieberman, analyst at ...
SG Americas Securities LLC lowered its stake in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP – Free Report) by 40.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The ...
On Jan. 17, Barclays PLC (BCS) reduced its price target for Keurig Dr Pepper to $36 from $39, while maintaining an “Overweight” rating on the stock. The analyst noted, "It feels like there ...
Keurig Dr Pepper Inc. (KDP), with a market cap of $43.5 billion, is a leading beverage company known for its diverse ...
Keurig Dr Pepper Inc. closed 17.55% short of its 52-week high of $38.28, which the company reached on September 24th.